Post-transcriptional regulation fine-tunes gene expression after RNA synthesis. This process involves RNA splicing, editing, stability control, and interference mechanisms, allowing cells to respond quickly to changing conditions without altering DNA.
These mechanisms add layers of complexity to gene regulation, expanding the proteome's diversity. They're crucial for normal development and cellular function, with dysregulation often linked to various diseases, highlighting their importance in biochemistry and medicine.
RNA Splicing and Editing
Alternative Splicing Mechanisms
Top images from around the web for Alternative Splicing Mechanisms
Eukaryotic Transcription gene regulation – Understanding Gene Regulation and Gene expression View original
Is this image relevant?
Alternative splicing - Wikipedia View original
Is this image relevant?
Eukaryotic Gene Regulation | Biology for Majors I View original
Is this image relevant?
Eukaryotic Transcription gene regulation – Understanding Gene Regulation and Gene expression View original
Is this image relevant?
Alternative splicing - Wikipedia View original
Is this image relevant?
1 of 3
Top images from around the web for Alternative Splicing Mechanisms
Eukaryotic Transcription gene regulation – Understanding Gene Regulation and Gene expression View original
Is this image relevant?
Alternative splicing - Wikipedia View original
Is this image relevant?
Eukaryotic Gene Regulation | Biology for Majors I View original
Is this image relevant?
Eukaryotic Transcription gene regulation – Understanding Gene Regulation and Gene expression View original
Is this image relevant?
Alternative splicing - Wikipedia View original
Is this image relevant?
1 of 3
- Alternative splicing generates multiple mRNA transcripts from a single gene
- Occurs in over 90% of human genes
- Involves differential selection of splice sites during pre-mRNA processing
- Produces protein isoforms with distinct functions or cellular localizations
- Regulated by tissue-specific or developmental stage-specific splicing factors
- Includes exon skipping, alternative 5' or 3' splice sites, and intron retention
- Contributes to proteome diversity without increasing genome size
- Dysregulation can lead to various diseases (muscular dystrophy, cancer)
RNA Editing Processes
- RNA editing alters the nucleotide sequence of RNA molecules after transcription
- Occurs in both coding and non-coding regions of RNA
- Most common form in mammals involves adenosine to inosine (A-to-I) conversion
- Catalyzed by adenosine deaminase acting on RNA (ADAR) enzymes
- Can change amino acid sequences, alter splicing patterns, or modify regulatory elements
- Plays crucial roles in neurotransmission, immune response, and development
- Editing sites often conserved across species, indicating functional importance
- Can create or destroy splice sites, affecting alternative splicing outcomes
mRNA Stability and Degradation
Factors Influencing mRNA Stability
- mRNA stability determines the duration of gene expression
- Stability varies widely among different mRNAs, from minutes to days
- Influenced by cis-acting elements in the mRNA sequence (AU-rich elements, stem-loop structures)
- Regulated by trans-acting factors (RNA-binding proteins, miRNAs)
- Affects protein synthesis rates and cellular responsiveness to stimuli
- Stability can be modulated in response to environmental cues or cellular stress
- Dysregulation of mRNA stability implicated in various diseases (inflammation, cancer)
Protective mRNA Structures
- Poly(A) tail protects mRNA from 3' to 5' exonucleolytic degradation
- Added to most eukaryotic mRNAs during processing in the nucleus
- Initial length typically 200-250 adenosine residues
- Gradually shortens over time, triggering mRNA decay when critically short
- Interacts with poly(A)-binding proteins (PABPs) to enhance stability and translation
- 5' cap structure (7-methylguanosine) protects mRNA from 5' to 3' exonucleolytic degradation
- Added co-transcriptionally to the 5' end of nascent mRNA
- Enhances mRNA stability, nuclear export, and translation initiation
- Recognized by cap-binding proteins involved in various mRNA processing steps
mRNA Quality Control Mechanisms
- Nonsense-mediated decay (NMD) eliminates mRNAs with premature stop codons
- Prevents production of truncated, potentially harmful proteins
- Involves recognition of stop codons upstream of exon-exon junctions
- Triggered by the interaction between terminating ribosomes and exon junction complexes
- Requires multiple protein factors, including UPF1, UPF2, and UPF3
- Also regulates expression of some normal transcripts with specific features
- Plays roles in development, cellular stress responses, and immune regulation
- Defects in NMD associated with various genetic disorders and cancers
RNA Interference
RNA Interference Mechanisms
- RNA interference (RNAi) silences gene expression through small RNA molecules
- Conserved mechanism found in many eukaryotes
- Involves degradation of target mRNAs or inhibition of their translation
- Triggered by double-stranded RNA (dsRNA) molecules
- Requires Dicer enzymes to process dsRNA into small RNA duplexes
- Utilizes Argonaute proteins to form RNA-induced silencing complexes (RISCs)
- Functions in gene regulation, defense against viruses, and genome stability
- Has applications in functional genomics research and potential therapeutics
microRNA Biogenesis and Function
- microRNAs (miRNAs) regulate gene expression post-transcriptionally
- Typically 21-23 nucleotides long, derived from longer primary transcripts
- Processed in the nucleus by Drosha and in the cytoplasm by Dicer
- Form imperfect base pairs with target mRNAs, usually in 3' UTRs
- Generally repress translation or induce mRNA degradation
- Single miRNA can target hundreds of different mRNAs
- Play crucial roles in development, differentiation, and disease processes
- Dysregulation of miRNAs implicated in various cancers and other disorders
siRNA Pathways and Applications
- Small interfering RNAs (siRNAs) mediate sequence-specific gene silencing
- Typically 21-23 nucleotides long, with perfect complementarity to their targets
- Can be endogenous (endo-siRNAs) or introduced experimentally
- Processed from long dsRNA precursors by Dicer enzymes
- Incorporated into RISCs to guide cleavage of complementary mRNAs
- Used as a tool for gene knockdown in research (RNA interference experiments)
- Potential therapeutic applications for targeting disease-causing genes
- Challenges include off-target effects and efficient delivery to target cells